These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 20851061)
1. In vitro activity of temocillin against planktonic and sessile Burkholderia cepacia complex bacteria. Van Acker H; Van Snick E; Nelis HJ; Coenye T J Cyst Fibros; 2010 Dec; 9(6):450-4. PubMed ID: 20851061 [TBL] [Abstract][Full Text] [Related]
2. In vitro activity of ceftazidime, ciprofloxacin, meropenem, minocycline, tobramycin and trimethoprim/sulfamethoxazole against planktonic and sessile Burkholderia cepacia complex bacteria. Peeters E; Nelis HJ; Coenye T J Antimicrob Chemother; 2009 Oct; 64(4):801-9. PubMed ID: 19633000 [TBL] [Abstract][Full Text] [Related]
3. The effect of recombinant human lactoferrin on growth and the antibiotic susceptibility of the cystic fibrosis pathogen Burkholderia cepacia complex when cultured planktonically or as biofilms. Caraher EM; Gumulapurapu K; Taggart CC; Murphy P; McClean S; Callaghan M J Antimicrob Chemother; 2007 Sep; 60(3):546-54. PubMed ID: 17595284 [TBL] [Abstract][Full Text] [Related]
4. Resistance of planktonic and biofilm-grown Burkholderia cepacia complex isolates to the transition metal gallium. Peeters E; Nelis HJ; Coenye T J Antimicrob Chemother; 2008 May; 61(5):1062-5. PubMed ID: 18310047 [TBL] [Abstract][Full Text] [Related]
5. Two case reports of the successful eradication of new isolates of Burkholderia cepacia complex in children with cystic fibrosis. Kitt H; Lenney W; Gilchrist FJ BMC Pharmacol Toxicol; 2016 Mar; 17():14. PubMed ID: 27018049 [TBL] [Abstract][Full Text] [Related]
7. Activity of Tobramycin against Cystic Fibrosis Isolates of Burkholderia cepacia Complex Grown as Biofilms. Kennedy S; Beaudoin T; Yau YC; Caraher E; Zlosnik JE; Speert DP; LiPuma JJ; Tullis E; Waters V Antimicrob Agents Chemother; 2016 Jan; 60(1):348-55. PubMed ID: 26503664 [TBL] [Abstract][Full Text] [Related]
8. Social interactions in the Burkholderia cepacia complex: biofilms and quorum sensing. Coenye T Future Microbiol; 2010 Jul; 5(7):1087-99. PubMed ID: 20632807 [TBL] [Abstract][Full Text] [Related]
9. In vitro activity of N-acetylcysteine against Stenotrophomonas maltophilia and Burkholderia cepacia complex grown in planktonic phase and biofilm. Pollini S; Di Pilato V; Landini G; Di Maggio T; Cannatelli A; Sottotetti S; Cariani L; Aliberti S; Blasi F; Sergio F; Rossolini GM; Pallecchi L PLoS One; 2018; 13(10):e0203941. PubMed ID: 30273348 [TBL] [Abstract][Full Text] [Related]
10. Temocillin in the treatment of Burkholderia cepacia infection in cystic fibrosis. Lekkas A; Gyi KM; Hodson ME J Cyst Fibros; 2006 May; 5(2):121-4. PubMed ID: 16650744 [TBL] [Abstract][Full Text] [Related]
11. In vitro interactions of tobramycin with various nonantibiotics against Pseudomonas aeruginosa and Burkholderia cenocepacia. Treerat P; Widmer F; Middleton PG; Iredell J; George AM FEMS Microbiol Lett; 2008 Aug; 285(1):40-50. PubMed ID: 18513356 [TBL] [Abstract][Full Text] [Related]
12. Sponge-associated microbial Antarctic communities exhibiting antimicrobial activity against Burkholderia cepacia complex bacteria. Papaleo MC; Fondi M; Maida I; Perrin E; Lo Giudice A; Michaud L; Mangano S; Bartolucci G; Romoli R; Fani R Biotechnol Adv; 2012; 30(1):272-93. PubMed ID: 21742025 [TBL] [Abstract][Full Text] [Related]
13. Antimicrobial susceptibility and synergy studies of Burkholderia cepacia complex isolated from patients with cystic fibrosis. Zhou J; Chen Y; Tabibi S; Alba L; Garber E; Saiman L Antimicrob Agents Chemother; 2007 Mar; 51(3):1085-8. PubMed ID: 17158942 [TBL] [Abstract][Full Text] [Related]
14. Investigating the role of matrix components in protection of Burkholderia cepacia complex biofilms against tobramycin. Messiaen AS; Nelis H; Coenye T J Cyst Fibros; 2014 Jan; 13(1):56-62. PubMed ID: 23932109 [TBL] [Abstract][Full Text] [Related]
15. In vitro efficacy of high-dose tobramycin against Burkholderia cepacia complex and Stenotrophomonas maltophilia isolates from cystic fibrosis patients. Ratjen A; Yau Y; Wettlaufer J; Matukas L; Zlosnik JE; Speert DP; LiPuma JJ; Tullis E; Waters V Antimicrob Agents Chemother; 2015 Jan; 59(1):711-3. PubMed ID: 25348526 [TBL] [Abstract][Full Text] [Related]
16. Resistance of the Burkholderia cepacia complex to fosmidomycin and fosmidomycin derivatives. Messiaen AS; Verbrugghen T; Declerck C; Ortmann R; Schlitzer M; Nelis H; Van Calenbergh S; Coenye T Int J Antimicrob Agents; 2011 Sep; 38(3):261-4. PubMed ID: 21724375 [TBL] [Abstract][Full Text] [Related]
17. Invasion and biofilm formation of Burkholderia dolosa is comparable with Burkholderia cenocepacia and Burkholderia multivorans. Caraher E; Duff C; Mullen T; Mc Keon S; Murphy P; Callaghan M; McClean S J Cyst Fibros; 2007 Jan; 6(1):49-56. PubMed ID: 16781896 [TBL] [Abstract][Full Text] [Related]
18. Activity of Cysteamine against the Cystic Fibrosis Pathogen Burkholderia cepacia Complex. Fraser-Pitt D; Mercer D; Lovie E; Robertson J; O'Neil D Antimicrob Agents Chemother; 2016 Oct; 60(10):6200-6. PubMed ID: 27503654 [TBL] [Abstract][Full Text] [Related]
19. Lung transplantation for patients with cystic fibrosis and Burkholderia cepacia complex infection: a single-center experience. De Soyza A; Meachery G; Hester KL; Nicholson A; Parry G; Tocewicz K; Pillay T; Clark S; Lordan JL; Schueler S; Fisher AJ; Dark JH; Gould FK; Corris PA J Heart Lung Transplant; 2010 Dec; 29(12):1395-404. PubMed ID: 20810293 [TBL] [Abstract][Full Text] [Related]
20. Comparison of antibiotic susceptibility of Burkholderia cepacia complex organisms when grown planktonically or as biofilm in vitro. Caraher E; Reynolds G; Murphy P; McClean S; Callaghan M Eur J Clin Microbiol Infect Dis; 2007 Mar; 26(3):213-6. PubMed ID: 17265071 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]